This brief provides recommendations for information sharing between medicolegal death investigators and toxicology laboratories in death investigations.
This publication outlines priority recommendations for medicolegal death investigators and toxicology laboratories to ensure the best possible U.S. death investigation outcomes. From 1999 to 2021, more than 1 million people in the United States died from a drug intoxication, with 106,699 occurring in 2021 alone. Drug intoxication deaths—from pharmaceutical or illicit drugs—are the leading cause of unintentional injury deaths in the U.S. Medicolegal death investigation offices work with toxicology laboratories to identify substances that may be relevant in establishing a decedent’s cause and manner of death. It is imperative to proactively establish cooperative relationships and information sharing to ensure the best possible outcome for families, health care organizations, toxicology testing services, MDIs, and other key data users.
Similar Publications
- Dual Pathways of Concealed Gun Carrying and Use from Adolescence to Adulthood over a 25-year Era of Change
- Targeted-Ion Mass Spectrometry for the Identification of Forensically Relevant Biological Fluids and Samples from Sexual Assault Evidence
- Computational methods for the interpretation of forensic DNA samples